Berry Genomics Co.,Ltd (SHE:000710)

Berry Genomics Co.,Ltd Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 25, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,415	2,987	4,073	4,034	6,804	13,348
Market Cap Growth	46.08%	-26.65%	0.96%	-40.71%	-49.03%	2.84%
Enterprise Value	4,417	2,894	4,164	4,122	6,884	13,477
Last Close Price	12.49	8.45	11.52	11.41	19.40	38.06
PE Ratio	-	-	-	-	-	63.36
Forward PE	-	39.28	39.28	39.28	51.73	42.29
PS Ratio	4.69	2.77	3.54	2.95	4.78	8.66
PB Ratio	2.68	1.74	2.15	1.73	2.70	5.51
P/TBV Ratio	2.80	1.83	2.26	1.80	2.81	5.75
P/FCF Ratio	-	95.70	72.85	-	-	273.73
P/OCF Ratio	109.07	33.96	36.69	190.46	72.35	82.75
EV/Sales Ratio	4.69	2.68	3.62	3.01	4.84	8.75
EV/EBITDA Ratio	-	-	-	-	135.14	45.61
EV/EBIT Ratio	-	-	-	-	-	61.65
EV/FCF Ratio	-99.75	92.70	74.48	-	-	276.38
Debt / Equity Ratio	0.18	0.09	0.16	0.15	0.16	0.15
Debt / EBITDA Ratio	-	-	-	-	6.66	1.22
Debt / FCF Ratio	-	5.14	5.43	-	-	7.37
Net Debt / Equity Ratio	-0.02	-0.14	-0.03	0.00	-0.01	-0.11
Net Debt / EBITDA Ratio	0.20	5.55	0.49	-0.30	-0.44	-0.93
Net Debt / FCF Ratio	0.64	-7.68	-0.87	-0.19	0.09	-5.61
Asset Turnover	0.39	0.42	0.39	0.41	0.42	0.49
Inventory Turnover	2.95	2.85	2.90	3.54	4.00	2.53
Quick Ratio	1.99	1.98	1.54	2.01	2.04	3.15
Current Ratio	2.49	2.44	1.93	2.45	2.48	3.61
Return on Equity (ROE)	-14.20%	-10.43%	-20.14%	-10.15%	-4.44%	8.63%
Return on Assets (ROA)	-5.09%	-2.91%	-4.18%	-2.33%	-0.86%	4.33%
Return on Invested Capital (ROIC)	-12.31%	-7.19%	-9.50%	-5.19%	-2.00%	8.56%
Return on Capital Employed (ROCE)	-10.90%	-6.70%	-10.10%	-5.00%	-1.70%	8.10%
Earnings Yield	-5.78%	-6.44%	-10.49%	-6.17%	-1.63%	1.58%
FCF Yield	-1.00%	1.04%	1.37%	-1.29%	-3.57%	0.36%
Payout Ratio	-	-	-	-	-	13.87%
Buyback Yield / Dilution	-0.34%	-0.00%	-15.04%	14.03%	-0.12%	-0.55%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.